The existing fusogen expressing EVs, such as vesicular stomatitis virus G protein (VSV-G), a class III fusion protein, decorated EVs, only reach the tumor lesion through enhanced permeability and retention effect, a passive targeting strategy. Here, PROS1 is linked to neoplasm.